Edgewise Therapeutics Inc
NASDAQ:EWTX
Edgewise Therapeutics Inc
NASDAQ:EWTX
Price:
29.66
USD
-1.53%
Market Closed
Market Cap:
$3.1B
Cash Flow Statement
Cash Flow Statement
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(17)
|
(21)
|
(27)
|
(36)
|
(43)
|
(51)
|
(56)
|
(61)
|
(68)
|
(76)
|
(81)
|
(89)
|
(100)
|
(106)
|
(116)
|
(124)
|
(134)
|
(146)
|
(151)
|
(157)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
3
|
4
|
6
|
7
|
9
|
11
|
13
|
15
|
16
|
18
|
19
|
20
|
22
|
25
|
29
|
31
|
33
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
3
|
4
|
7
|
9
|
10
|
11
|
10
|
8
|
7
|
8
|
8
|
9
|
10
|
12
|
18
|
22
|
24
|
|
| Change in Working Capital |
2
|
2
|
2
|
5
|
5
|
4
|
1
|
(0)
|
4
|
3
|
5
|
4
|
(2)
|
(2)
|
2
|
3
|
10
|
8
|
2
|
(1)
|
|
| Cash from Operating Activities |
(15)
N/A
|
(18)
-23%
|
(24)
-32%
|
(29)
-21%
|
(34)
-17%
|
(40)
-19%
|
(47)
-16%
|
(50)
-8%
|
(53)
-5%
|
(63)
-19%
|
(67)
-6%
|
(77)
-15%
|
(92)
-20%
|
(98)
-6%
|
(104)
-6%
|
(109)
-5%
|
(109)
0%
|
(118)
-9%
|
(125)
-5%
|
(132)
-6%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(6)
|
(10)
|
(10)
|
(9)
|
(6)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
(24)
|
(89)
|
(249)
|
(280)
|
(242)
|
(145)
|
15
|
21
|
(65)
|
(43)
|
(40)
|
9
|
109
|
(213)
|
(179)
|
(177)
|
(183)
|
129
|
(71)
|
(61)
|
|
| Cash from Investing Activities |
(24)
N/A
|
(89)
-266%
|
(249)
-179%
|
(281)
-13%
|
(242)
+14%
|
(146)
+40%
|
14
N/A
|
19
+38%
|
(71)
N/A
|
(53)
+25%
|
(49)
+7%
|
0
N/A
|
103
+34 195%
|
(214)
N/A
|
(181)
+16%
|
(179)
+1%
|
(185)
-3%
|
128
N/A
|
(72)
N/A
|
(62)
+14%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
120
|
307
|
306
|
281
|
187
|
(0)
|
1
|
131
|
130
|
130
|
130
|
0
|
53
|
294
|
295
|
299
|
249
|
10
|
196
|
194
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash from Financing Activities |
120
N/A
|
307
+155%
|
306
0%
|
281
-8%
|
186
-34%
|
(1)
N/A
|
1
N/A
|
130
+22 360%
|
130
0%
|
130
0%
|
130
+0%
|
(0)
N/A
|
53
N/A
|
294
+453%
|
296
+1%
|
299
+1%
|
249
-17%
|
10
-96%
|
197
+1 791%
|
195
-1%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
81
N/A
|
200
+146%
|
34
-83%
|
(28)
N/A
|
(89)
-217%
|
(187)
-109%
|
(32)
+83%
|
99
N/A
|
6
-94%
|
14
+114%
|
13
-2%
|
(77)
N/A
|
64
N/A
|
(18)
N/A
|
12
N/A
|
12
+1%
|
(44)
N/A
|
20
N/A
|
(0)
N/A
|
1
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(18)
-23%
|
(24)
-31%
|
(29)
-23%
|
(34)
-17%
|
(41)
-20%
|
(48)
-17%
|
(53)
-10%
|
(58)
-11%
|
(72)
-25%
|
(77)
-6%
|
(86)
-12%
|
(98)
-14%
|
(99)
-2%
|
(105)
-5%
|
(110)
-5%
|
(110)
0%
|
(119)
-8%
|
(126)
-5%
|
(133)
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
